Core Viewpoint - Beam Global reported a successful second quarter in 2025, achieving revenue growth and the highest GAAP Gross Margin in its history, while expanding its global market presence through the establishment of Beam Middle East [4]. Financial Highlights - Revenues for Q2 2025 were $7.1 million, a 12% increase from Q1 2025 [5]. - 60% of revenues for the first half of 2025 came from commercial customers, with 37% from international operations [5][6]. - GAAP Gross Margin was 20% for Q2 2025, up 4 percentage points from Q2 2024, while adjusted non-GAAP Gross Margin was 30%, a 12 percentage point increase from the previous year [5][7]. - Operating costs decreased by $1.2 million, or 17%, compared to Q2 2024 [8]. - The net loss for Q2 2025 was $4.3 million, an improvement from $4.9 million in Q2 2024 [9]. Recent Operational Highlights - Beam Global established Beam Middle East LLC, a joint venture to sell and manufacture products in the Middle East and Africa [5]. - The company shipped products to 13 U.S. states and multiple European countries, including Serbia, Romania, and Croatia [5]. - Beam Global received a Sustainability Award for Innovation in Infrastructure at the 2025 Romanian Mayors Congress [5]. - The company expanded its energy storage systems business, securing contracts totaling $2.5 million with defense customers [5]. Cash Position - As of June 30, 2025, Beam Global had cash of $3.4 million, an increase from $2.5 million at the end of Q1 2025 [10]. - The company remains debt-free with a $100 million line of credit available and unused [5]. Company Overview - Beam Global is a clean technology innovator focused on sustainable energy infrastructure and electric vehicle charging solutions, with operations in the U.S., Europe, and the Middle East [15]. - The company develops and manufactures advanced clean technology solutions aimed at enhancing energy security and supporting smart city initiatives [15].

– Well-tolerated safety profile and robust broad-spectrum efficacy sustained over 1-year across all symptom domains including negative symptoms in open label extension (OLE) 1-year trial– – Successful completion of two large randomized double-blind clinical trials, including one Phase 2 and one Phase 3 trial, a 1-year OLE trial, and clinical pharmacology studies designed to support filing of New Drug Application (NDA) – – Planned meeting with Food and Drug Administration (FDA) to discuss brilaroxazine’s pat ...

Breton Hill by Toll Brothers will feature only 13 new homes on up to one-acre home sites with serene views in historic Warwick TownshipFORT WASHINGTON, Pa., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced its newest Bucks County community, Breton Hill by Toll Brothers, is coming soon to Warwick Township, Pennsylvania. Site work is underway, and the community is expected to open for sale in late 2025. Located in sought-after Warw ...

Core Insights - Eledon Pharmaceuticals reported positive data from an ongoing Phase 1b trial of tegoprubart, showing a mean 12-month estimated glomerular filtration rate (eGFR) of approximately 68 mL/min/1.73 m for kidney transplant patients, significantly higher than the historical mean of 53 mL/min/1.73 m with standard care [1][3] - The company is on track to release topline results from the Phase 2 BESTOW trial in kidney transplantation in November 2025 [1][10] - Eledon has a cash position of $107.6 million as of June 30, 2025, which is expected to fund operations through the end of 2026 [1][5] Business Highlights - Eledon achieved key milestones in advancing tegoprubart for kidney, islet cell, and liver transplantation, as well as xenotransplantation [2] - Updated data presented at the World Transplant Congress indicated that tegoprubart was well tolerated with no severe adverse events reported [3] - The company announced the first three islet cell transplant recipients treated with tegoprubart at the University of Chicago, achieving insulin independence [3] Financial Results - Research and development expenses for Q2 2025 were $20.3 million, up from $10.1 million in Q2 2024 [6] - General and administrative expenses for Q2 2025 were $4.5 million, slightly higher than $4.4 million in Q2 2024 [7] - The net loss for Q2 2025 was $11.2 million, a significant reduction from a net loss of $44.9 million in Q2 2024 [7][16] Upcoming Milestones - The company plans to report topline results from the Phase 2 BESTOW trial in November 2025 [10] - Eledon will launch an investigator-initiated trial at Massachusetts General Hospital to evaluate tegoprubart for inducing donor-specific immune tolerance [10]

HOUSTON, Aug. 14, 2025 (GLOBE NEWSWIRE) -- KULR Technology Group, Inc. (NYSE American: KULR) (the "Company" or "KULR"), a Bitcoin-Plus Treasury company that builds a portfolio of frontier technology businesses ranging from high performance energy systems to AI Robotics, today reported results for the second quarter ended June 30, 2025. “KULR is in its strongest financial position to accelerate its growth and continue its innovations," commented KULR CEO Michael Mo. "Alongside the increased revenue in Q2, o ...

From Innovation to Policy: OPT Leverages Proven Marine Energy Track Record to Help Shape the FutureMONROE TOWNSHIP, N.J., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Ocean Power Technologies, Inc. (NYSE American: OPTT) (“OPT” or the “Company”), a leader in innovative, low-carbon offshore power, data, and service solutions, today announced its participation in a joint hearing of the New Jersey Assembly Environment, Natural Resources, and Solid Waste Committee and the Senate Environment and Energy Committee. The sessio ...

~ Q2 Gross Margin Expansion, Cost Reductions, Strategic Transactions, and Diversified Revenue Initiatives Could Position Super League to Achieve Adjusted EBITDA Positive in Q4 ~ ~ Company Advances Key Financial Initiatives and Broadens Revenue Mix ~ SANTA MONICA, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Super League (Nasdaq: SLE), a leader in engaging audiences through playable media, content, and experiences within mobile games and the world’s largest immersive platforms, today released second quarter 202 ...

LOS ANGELES, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Nova LifeStyle, Inc. (NASDAQ: NVFY) (“Nova LifeStyle” or the “Company”) today announced its financial results for the second quarter ended June 30, 2025. Key Financial Highlights: Operating Results for the Three Months Ended June 30, 2025: Net sales for three months ended June 30, 2025 were $2.56 million, a decrease of 5% from $2.69 million in the same period of 2024.Gross profit was $1.28 million compared to $1.19 million in the same period of 2024.Net loss wa ...

SAN RAMON, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today it will participate in the Wells Fargo Healthcare Conference on Wednesday, September 3, 2025. Al White, President and CEO, will represent the Company in a session scheduled at 3:00 PM ET. The webcast will be available to investors and other interested parties by accessing the CooperCompanies’ website at http://investor.coopercos.com. About CooperCompaniesCooperCompanie ...

Core Insights - Itron, Inc. has appointed Sheri Savage, former CFO of Ultra Clean Holdings, to its board of directors, effective August 11, 2025, bringing over 30 years of finance experience [1][2]. Company Overview - Itron is focused on innovating solutions for utilities and cities to manage energy and water, aiming to improve efficiency and deliver reliable services [5]. Leadership Experience - Sheri Savage has held multiple leadership roles at Ultra Clean Holdings since 2009, becoming CFO in 2016 and leading the company through significant revenue and earnings growth [2]. - Prior to her role at UCT, Savage served as corporate controller and vice president of finance at Credence Systems Corporation, and held various roles at Protiviti and KLA-Tencor Corporation [2]. Board Expectations - The chair of Itron's board, Diana Tremblay, highlighted Savage's strategic financial leadership and extensive experience in various financial domains as key qualifications for her board position [3]. - Itron's CEO, Tom Deitrich, expressed confidence that Savage's experience in public company finance will be beneficial for advancing the company's business strategy and enhancing shareholder value [4].